Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.

  • Authors : Ahmed S; Department of Basic Sciences, University of Veterinary and Animal Sciences Lahore, 51600 Narowal, Pakistan.; Ullah N

Subjects: Antioxidants/Antioxidants/Antioxidants/*administration & dosage ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Hepacivirus/Hepacivirus/Hepacivirus/*genetics

  • Source: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Feb 02; Vol. 2022, pp. 9199190. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101479826 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dengue virus is sensitive to inhibition prior to productive replication.

  • Authors : Talemi SR; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bartenschlager M

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Dengue Virus/Dengue Virus/Dengue Virus/*drug effects ; Ribavirin/Ribavirin/Ribavirin/*pharmacology

  • Source: Cell reports [Cell Rep] 2021 Oct 12; Vol. 37 (2), pp. 109801.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247

Record details

×
Academic Journal

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients.

  • Authors : Grubczak K; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Białystok, Poland.; Grzeszczuk A

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Hepatitis C/Hepatitis C/Hepatitis C/*drug therapy

  • Source: Viruses [Viruses] 2021 Jul 25; Vol. 13 (8). Date of Electronic Publication: 2021 Jul 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

Association of Autoantibody to Rods and Rings with Hepatitis C Outcome and Viral Load.

  • Authors : Dhaouadi T; 1 Research Laboratory in Immunology of Renal Transplantation and Immunopathology (LR03SP01), Charles Nicolle Hospital, Tunis El Manar University, Tunis, Tunisia.; Abdellatif J

Subjects: Viral Load*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Autoantibodies/Autoantibodies/Autoantibodies/*blood

  • Source: Viral immunology [Viral Immunol] 2019 Jun; Vol. 32 (5), pp. 214-220. Date of Electronic Publication: 2019 May 13.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 8801552 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.

Subjects: Amides*/Amides*/Amides*/pharmacokinetics ; Amides*/Amides*/Amides*/pharmacology ; Amides*/Amides*/Amides*/therapeutic use

  • Source: PLoS computational biology [PLoS Comput Biol] 2021 Jan 07; Vol. 17 (1), pp. e1008535. Date of Electronic Publication: 2021 Jan 07 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir-boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection.

  • Authors : Xiao L; Infections Department, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; Wu X

Subjects: Ribavirin*/Ribavirin*/Ribavirin*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Proline*/Proline*/Proline*/analogs & derivatives

  • Source: Journal of medical virology [J Med Virol] 2020 Dec; Vol. 92 (12), pp. 3516-3524. Date of Electronic Publication: 2020 Jun 29.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.

  • Authors : Lawitz E; Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, USA.; Landis CS

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Fluorenes/Fluorenes/Fluorenes/*therapeutic use

  • Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Oct; Vol. 5 (10), pp. 918-926. Date of Electronic Publication: 2020 Jun 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.

  • Authors : Gheorghe LS; Carol Davila University of Medicine and Pharmacy, Gastroenterol and Hepatol Depart, Clinic Fundeni Institute, Bucharest, Romania. . .; Preda C

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Fluorenes/Fluorenes/Fluorenes/*therapeutic use

  • Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2020 Sep 09; Vol. 29 (3), pp. 385-390. Date of Electronic Publication: 2020 Sep 09.Publisher:

Record details

×
Academic Journal

Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.

  • Authors : Akhmedov M; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Wais V

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*adverse effects ; Paramyxoviridae Infections/Paramyxoviridae Infections/Paramyxoviridae Infections/*etiology

  • Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Aug; Vol. 22 (4), pp. e13276. Date of Electronic Publication: 2020 Apr Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treating chronic hepatitis E: when is enough enough?

  • Authors : Evans TJ; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Hilton R

Subjects: Viral Load*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Feces/Feces/Feces/*virology

  • Source: BMJ case reports [BMJ Case Rep] 2018 Feb 01; Vol. 2018. Date of Electronic Publication: 2018 Feb 01.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

×
  • 1-10 of  1,104 results for ""VIRAL load""